Holding in Company
2008年7月31日 - 12:18AM
RNSを含む英国規制内ニュース (英語)
RNS Number : 2471A
Northwest Biotherapeutics Inc
30 July 2008
For Immediate Release 30 July 2008
Northwest Biotherapeutics
("NWBT" or the "Company")
Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announced it has issued 146,768 shares of common stock $0.001 par
value, representing 0.3466% of the issued share capital. The shares were issued in fulfillment of a US$ 225,000 consideration for an option
to acquire certain assets of MithraGen Corporation and in fulfillment of the exercise of certain employee stock options. The shares were
issued as follows: 754 shares on 17 April 2008 at a price of $2.267 per share; 122,190 shares on 17 June 2008 at $1.8414 per share and
23,824 shares on 27 June 2008 at $0.60 per share.
Application has been made today for the shares to be admitted to trading on AIM on 5 August 2008.
For further information, please contact:
Northwest Biotherapeutics
Anthony P. Deasey, Chief Financial Officer +1 240-497-9024
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane +44 (0)20 7466 5000
Johnson / Catherine Breen
Collins Stewart
Adam Cowen/Tim Mickley +44 (0)20 7523 8230
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFKKKDPBKDOON
Northw.Bio Regs (LSE:NWBS)
過去 株価チャート
から 5 2024 まで 6 2024
Northw.Bio Regs (LSE:NWBS)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Northw.Bio Regs (ロンドン証券取引所): 0 recent articles
その他のNorthwest Bio.ニュース記事